Cargando…

Nicotinamide Increases Intracellular NAD(+) Content to Enhance Autophagy-Mediated Group A Streptococcal Clearance in Endothelial Cells

Group A streptococcus (GAS) is a versatile pathogen that causes a wide spectrum of diseases in humans. Invading host cells is a known strategy for GAS to avoid antibiotic killing and immune recognition. However, the underlying mechanisms of GAS resistance to intracellular killing need to be explored...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Cheng-Lu, Hsieh, Shu-Ying, Huang, Hsuan-Min, Lu, Shiou-Ling, Omori, Hiroko, Zheng, Po-Xing, Ho, Yen-Ning, Cheng, Yi-Lin, Lin, Yee-Shin, Chiang-Ni, Chuan, Tsai, Pei-Jane, Wang, Shu-Ying, Liu, Ching-Chuan, Noda, Takeshi, Wu, Jiunn-Jong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026195/ https://www.ncbi.nlm.nih.gov/pubmed/32117141 http://dx.doi.org/10.3389/fmicb.2020.00117

Ejemplares similares

NAD-Glycohydrolase Depletes Intracellular NAD(+) and Inhibits Acidification of Autophagosomes to Enhance Multiplication of Group A Streptococcus in Endothelial Cells
por: Hsieh, Cheng-Lu, et al.
Publicado: (2018)

VEGF-Mediated Augmentation of Autophagic and Lysosomal Activity in Endothelial Cells Defends against Intracellular Streptococcus pyogenes
por: Lu, Shiou-Ling, et al.
Publicado: (2022)

Streptococcal pyrogenic exotoxin B inhibits apoptotic cell clearance by macrophages through protein S cleavage
por: Chen, Chia-Ling, et al.
Publicado: (2016)

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD(+) by Generating Dihydronicotinamide Riboside
por: Ciarlo, Eleonora, et al.
Publicado: (2022)

Cloning and Organelle Expression of Bamboo Mitochondrial Complex I Subunits Nad1, Nad2, Nad4, and Nad5 in the Yeast Saccharomyces cerevisiae
por: Tsai, Hsieh-Chin, et al.
Publicado: (2022)

Group A Streptococcus Induces LAPosomes via SLO/β1 Integrin/NOX2/ROS Pathway in Endothelial Cells That Are Ineffective in Bacterial Killing and Suppress Xenophagy
por: Cheng, Yi-Lin, et al.
Publicado: (2019)

Erratum for Cheng et al., “Group A Streptococcus Induces LAPosomes via SLO/β1 Integrin/NOX2/ROS Pathway in Endothelial Cells That Are Ineffective in Bacterial Killing and Suppress Xenophagy”
por: Cheng, Yi-Lin, et al.
Publicado: (2021)

Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection
por: Kuo, Chih-Feng, et al.
Publicado: (2017)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

Replicatively senescent human fibroblasts reveal a distinct intracellular metabolic profile with alterations in NAD+ and nicotinamide metabolism
por: James, Emma L., et al.
Publicado: (2016)

Nicotinamide ameliorates mitochondria-related neuronal apoptosis and cognitive impairment via the NAD(+)/SIRT3 pathway
por: Hao, Keke, et al.
Publicado: (2023)

The emergence of the nicotinamide riboside kinases in the regulation of NAD(+) metabolism
por: Fletcher, Rachel S, et al.
Publicado: (2018)

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023)

The Effect of Nicotinamide Riboside, an NAD + Precursor, on Glycolysis and NAD + Salvage Pathway in Alcohol-Stimulated Macrophages
por: Kang, Hyunju, et al.
Publicado: (2022)

Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD)
por: Yaku, Keisuke, et al.
Publicado: (2019)

Prediction of Diagnosis-Related Groups for Appendectomy Patients Using C4.5 and Neural Network
por: Chiang, Yi-Cheng, et al.
Publicado: (2023)

Nicotinamide Riboside Kinase Structures Reveal New Pathways to NAD(+)
por: Tempel, Wolfram, et al.
Publicado: (2007)

The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats
por: Kourtzidis, Ioannis A., et al.
Publicado: (2016)

Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations
por: Cercillieux, Angelique, et al.
Publicado: (2022)

A Novel Endogenous Inhibitor of the Secreted Streptococcal NAD-Glycohydrolase
por: Meehl, Michael A, et al.
Publicado: (2005)

Nicotinamide restores tissue NAD(+) and improves survival in rodent models of cardiac arrest
por: Zhu, Xiangdong, et al.
Publicado: (2023)

Impaired nicotinamide adenine dinucleotide (NAD(+)) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment
por: Fan, Lan, et al.
Publicado: (2020)

Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2
por: Hasegawa, Kazuhiro, et al.
Publicado: (2022)

Nicotinamide mononucleotide adenylyltransferase uses its NAD(+) substrate-binding site to chaperone phosphorylated Tau
por: Ma, Xiaojuan, et al.
Publicado: (2020)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
por: Sverkeli, Lars Jansen, et al.
Publicado: (2021)

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
por: Navas, Lola E., et al.
Publicado: (2022)

Nicotinamide Phosphoribosyltransferase‐elevated NAD(+) biosynthesis prevents muscle disuse atrophy by reversing mitochondrial dysfunction
por: Zhang, Yao, et al.
Publicado: (2023)

Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway
por: Feng, Duo, et al.
Publicado: (2020)

Nicotinamide Mononucleotide, an Intermediate of NAD(+) Synthesis, Protects the Heart from Ischemia and Reperfusion
por: Yamamoto, Takanobu, et al.
Publicado: (2014)

Potential of nicotinamide adenine dinucleotide (NAD) for management of root-knot nematode in tomato
por: Regmi, Homan, et al.
Publicado: (2021)

Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms
por: Torres-Méndez, Jeimy Katherine, et al.
Publicado: (2023)

A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor
por: Giroud-Gerbetant, Judith, et al.
Publicado: (2019)

4582 NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) DEPLETION MUST BE SEVERE TO INDUCE CARDIAC DYSFUNCTION AND EVENTUAL FAILURE
por: Luongo, Timothy, et al.
Publicado: (2020)

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
por: Hong, Weiqi, et al.
Publicado: (2020)

NAD(+) augmentation with nicotinamide riboside improves lymphoid potential of Atm(−/−) and old mice HSCs
por: Zong, Le, et al.
Publicado: (2021)

The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions
por: Fortunato, Carlo, et al.
Publicado: (2021)

Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2014)

Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD(+)–Sirt1 signaling
por: Pi, Chenchen, et al.
Publicado: (2019)

Genistein suppresses the proliferation of telomerase‐negative cells
por: Lin, Chuan‐Chuan, et al.
Publicado: (2016)

Interleukin-17A Contributes to Bacterial Clearance in a Mouse Model of Streptococcal Toxic Shock-Like Syndrome
por: Xu, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9jeakot0nvoms9tqdqoak1ofj